ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,745,865 | +13.7% | 1,132,378 | +5.4% | 0.00% | +100.0% |
| Q2 2023 | $57,822,787 | +74.5% | 1,074,174 | +28.8% | 0.00% | 0.0% |
| Q1 2023 | $33,134,822 | +1.4% | 834,210 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $32,691,864 | +29.1% | 812,624 | +3.1% | 0.00% | 0.0% |
| Q3 2022 | $25,325,000 | +4.8% | 787,923 | -3.2% | 0.00% | 0.0% |
| Q2 2022 | $24,157,000 | +10.8% | 814,174 | +5.0% | 0.00% | 0.0% |
| Q1 2022 | $21,793,000 | -34.0% | 775,299 | +8.2% | 0.00% | 0.0% |
| Q4 2021 | $33,029,000 | +56.1% | 716,776 | +11.2% | 0.00% | 0.0% |
| Q3 2021 | $21,163,000 | -2.5% | 644,814 | +4.1% | 0.00% | 0.0% |
| Q2 2021 | $21,706,000 | -8.9% | 619,325 | -6.0% | 0.00% | 0.0% |
| Q1 2021 | $23,816,000 | +36.0% | 659,005 | +9.2% | 0.00% | 0.0% |
| Q4 2020 | $17,518,000 | +9.3% | 603,222 | +6.2% | 0.00% | 0.0% |
| Q3 2020 | $16,023,000 | -9.8% | 567,945 | +3.4% | 0.00% | 0.0% |
| Q2 2020 | $17,769,000 | -26.1% | 549,440 | -7.0% | 0.00% | 0.0% |
| Q1 2020 | $24,058,000 | -32.3% | 590,535 | +2.5% | 0.00% | 0.0% |
| Q4 2019 | $35,536,000 | -16.8% | 576,230 | -1.6% | 0.00% | -50.0% |
| Q3 2019 | $42,689,000 | -8.0% | 585,741 | +3.8% | 0.00% | 0.0% |
| Q2 2019 | $46,387,000 | +19.2% | 564,317 | +2.3% | 0.00% | 0.0% |
| Q1 2019 | $38,899,000 | +63.8% | 551,458 | +4.5% | 0.00% | +100.0% |
| Q4 2018 | $23,751,000 | -19.6% | 527,560 | +0.9% | 0.00% | 0.0% |
| Q3 2018 | $29,559,000 | -14.0% | 522,813 | +1.6% | 0.00% | 0.0% |
| Q2 2018 | $34,378,000 | +19.6% | 514,640 | +4.2% | 0.00% | 0.0% |
| Q1 2018 | $28,744,000 | -7.3% | 493,706 | +2.6% | 0.00% | 0.0% |
| Q4 2017 | $31,015,000 | +24.4% | 481,229 | +1.3% | 0.00% | 0.0% |
| Q3 2017 | $24,923,000 | +11.7% | 474,829 | -0.4% | 0.00% | 0.0% |
| Q2 2017 | $22,322,000 | +2.2% | 476,948 | +8.1% | 0.00% | 0.0% |
| Q1 2017 | $21,845,000 | -13.7% | 441,226 | +5.7% | 0.00% | 0.0% |
| Q4 2016 | $25,304,000 | -1.9% | 417,420 | +7.3% | 0.00% | -50.0% |
| Q3 2016 | $25,807,000 | +19.9% | 388,940 | +0.8% | 0.00% | +100.0% |
| Q2 2016 | $21,527,000 | +72.9% | 385,670 | +4.3% | 0.00% | 0.0% |
| Q1 2016 | $12,451,000 | -23.5% | 369,910 | +2.5% | 0.00% | 0.0% |
| Q4 2015 | $16,286,000 | -94.5% | 360,913 | -95.3% | 0.00% | -90.9% |
| Q3 2015 | $298,720,000 | +1305.5% | 7,614,553 | +2123.3% | 0.01% | +1000.0% |
| Q2 2015 | $21,253,000 | +14.3% | 342,495 | +15.2% | 0.00% | 0.0% |
| Q1 2015 | $18,590,000 | +45.8% | 297,208 | +31.4% | 0.00% | 0.0% |
| Q4 2014 | $12,752,000 | +101.0% | 226,136 | +0.8% | 0.00% | – |
| Q3 2014 | $6,345,000 | -12.1% | 224,371 | +7.0% | 0.00% | -100.0% |
| Q2 2014 | $7,219,000 | +15.7% | 209,613 | +5.4% | 0.00% | 0.0% |
| Q1 2014 | $6,237,000 | +188.5% | 198,950 | +84.7% | 0.00% | – |
| Q4 2013 | $2,162,000 | +153.8% | 107,694 | +23.6% | 0.00% | – |
| Q3 2013 | $852,000 | – | 87,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |